

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65662062 |
| 2 | lysine catabolic process (GO:0006554) | 4.50369520 |
| 3 | lysine metabolic process (GO:0006553) | 4.50369520 |
| 4 | valine metabolic process (GO:0006573) | 4.38164614 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32575273 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 4.26892170 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.07116777 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.07116777 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.06418879 |
| 10 | pentose-phosphate shunt (GO:0006098) | 3.96631763 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.94391071 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94391071 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94391071 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94391071 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.94391071 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94391071 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.93157629 |
| 18 | tricarboxylic acid metabolic process (GO:0072350) | 3.87092887 |
| 19 | carnitine shuttle (GO:0006853) | 3.82846380 |
| 20 | viral transcription (GO:0019083) | 3.81587980 |
| 21 | response to peptidoglycan (GO:0032494) | 3.79614386 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 3.77038155 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 3.75437941 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71608050 |
| 25 | translational termination (GO:0006415) | 3.68985450 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.68375522 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68205847 |
| 28 | cysteine metabolic process (GO:0006534) | 3.65518460 |
| 29 | regulation of sequestering of triglyceride (GO:0010889) | 3.65197615 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62315025 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.58982698 |
| 32 | NADPH regeneration (GO:0006740) | 3.56139131 |
| 33 | maternal placenta development (GO:0001893) | 3.54314747 |
| 34 | carnitine transport (GO:0015879) | 3.53819186 |
| 35 | amino-acid betaine transport (GO:0015838) | 3.53819186 |
| 36 | response to type I interferon (GO:0034340) | 3.47747021 |
| 37 | regulation of fatty acid oxidation (GO:0046320) | 3.47626540 |
| 38 | translational elongation (GO:0006414) | 3.46765055 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.45482636 |
| 40 | oxidative phosphorylation (GO:0006119) | 3.44638301 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.44468214 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.44468214 |
| 43 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.44025941 |
| 44 | carnitine transmembrane transport (GO:1902603) | 3.42755021 |
| 45 | macrophage activation (GO:0042116) | 3.42323034 |
| 46 | negative regulation of interleukin-12 production (GO:0032695) | 3.41799354 |
| 47 | NADH metabolic process (GO:0006734) | 3.39593769 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38762780 |
| 49 | negative regulation of cell size (GO:0045792) | 3.38615358 |
| 50 | 4-hydroxyproline metabolic process (GO:0019471) | 3.38412533 |
| 51 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.37417685 |
| 52 | detection of other organism (GO:0098543) | 3.36106283 |
| 53 | fatty acid oxidation (GO:0019395) | 3.34938802 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30955176 |
| 55 | detection of bacterium (GO:0016045) | 3.30645084 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28575221 |
| 57 | microglial cell activation (GO:0001774) | 3.28169041 |
| 58 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25762568 |
| 59 | lipid oxidation (GO:0034440) | 3.25001022 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23595276 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22970143 |
| 62 | aspartate family amino acid catabolic process (GO:0009068) | 3.17684815 |
| 63 | fatty acid catabolic process (GO:0009062) | 3.17101037 |
| 64 | respiratory burst (GO:0045730) | 3.11905213 |
| 65 | oxaloacetate metabolic process (GO:0006107) | 3.09406451 |
| 66 | carnitine metabolic process (GO:0009437) | 3.08966000 |
| 67 | regulation of necroptotic process (GO:0060544) | 3.04972718 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03636071 |
| 69 | branched-chain amino acid metabolic process (GO:0009081) | 3.03118724 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00332249 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 2.99619776 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.98939176 |
| 73 | hepatocyte apoptotic process (GO:0097284) | 2.97112208 |
| 74 | quaternary ammonium group transport (GO:0015697) | 2.96177215 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95528389 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95361231 |
| 77 | short-chain fatty acid metabolic process (GO:0046459) | 2.95009754 |
| 78 | positive regulation of interferon-alpha production (GO:0032727) | 2.94361264 |
| 79 | oxygen transport (GO:0015671) | 2.93998282 |
| 80 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.92120283 |
| 81 | alpha-linolenic acid metabolic process (GO:0036109) | 2.89106194 |
| 82 | succinate metabolic process (GO:0006105) | 2.89042474 |
| 83 | translational initiation (GO:0006413) | 2.88948927 |
| 84 | protein targeting to ER (GO:0045047) | 2.87475072 |
| 85 | germinal center formation (GO:0002467) | 2.86316970 |
| 86 | leukocyte aggregation (GO:0070486) | 2.86285696 |
| 87 | amino-acid betaine metabolic process (GO:0006577) | 2.85981728 |
| 88 | response to mercury ion (GO:0046689) | 2.85819669 |
| 89 | branched-chain amino acid catabolic process (GO:0009083) | 2.85333389 |
| 90 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85273890 |
| 91 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85273890 |
| 92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83997537 |
| 93 | defense response to protozoan (GO:0042832) | 2.83691131 |
| 94 | cellular protein complex disassembly (GO:0043624) | 2.83302165 |
| 95 | neutrophil activation (GO:0042119) | 2.83290860 |
| 96 | granulocyte activation (GO:0036230) | 2.82802994 |
| 97 | response to protozoan (GO:0001562) | 2.82262797 |
| 98 | detection of external biotic stimulus (GO:0098581) | 2.82077569 |
| 99 | viral life cycle (GO:0019058) | 2.81810148 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80959167 |
| 101 | response to host immune response (GO:0052572) | 2.80959167 |
| 102 | triglyceride catabolic process (GO:0019433) | 2.80798217 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80540132 |
| 104 | cellular response to virus (GO:0098586) | 2.80105823 |
| 105 | B cell mediated immunity (GO:0019724) | 2.79972023 |
| 106 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.79631409 |
| 107 | neutrophil mediated immunity (GO:0002446) | 2.79630099 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 2.78627880 |
| 109 | ethanol oxidation (GO:0006069) | 2.78627343 |
| 110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77165567 |
| 111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.76839089 |
| 112 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.76666995 |
| 113 | cotranslational protein targeting to membrane (GO:0006613) | 2.76084050 |
| 114 | epithelial cell-cell adhesion (GO:0090136) | 2.73572473 |
| 115 | ribosomal small subunit assembly (GO:0000028) | 2.72305274 |
| 116 | regulation of necrotic cell death (GO:0010939) | 2.71014916 |
| 117 | positive regulation of granulocyte differentiation (GO:0030854) | 2.70767216 |
| 118 | regulation of cholesterol storage (GO:0010885) | 2.70579499 |
| 119 | positive thymic T cell selection (GO:0045059) | 2.70140499 |
| 120 | protein localization to endoplasmic reticulum (GO:0070972) | 2.70054383 |
| 121 | positive regulation of fatty acid oxidation (GO:0046321) | 2.69834429 |
| 122 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.69331428 |
| 123 | glucose catabolic process (GO:0006007) | 2.69187486 |
| 124 | sarcomere organization (GO:0045214) | 2.68518600 |
| 125 | positive regulation of lipid storage (GO:0010884) | 2.68082146 |
| 126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.67509906 |
| 127 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.66836607 |
| 128 | heme biosynthetic process (GO:0006783) | 2.65234731 |
| 129 | plasma membrane repair (GO:0001778) | 2.65013202 |
| 130 | positive regulation of B cell differentiation (GO:0045579) | 2.64854519 |
| 131 | peptidyl-proline hydroxylation (GO:0019511) | 2.64572714 |
| 132 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.63953275 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 2.63739342 |
| 134 | DNA deamination (GO:0045006) | 2.62985891 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62871562 |
| 136 | reactive oxygen species biosynthetic process (GO:1903409) | 2.62682089 |
| 137 | glyoxylate metabolic process (GO:0046487) | 2.62051559 |
| 138 | NADP metabolic process (GO:0006739) | 2.61600326 |
| 139 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.61013496 |
| 140 | positive regulation of histone deacetylation (GO:0031065) | 2.60156667 |
| 141 | galactose catabolic process (GO:0019388) | 2.60130239 |
| 142 | protein hydroxylation (GO:0018126) | 2.59649924 |
| 143 | acetyl-CoA metabolic process (GO:0006084) | 2.59295038 |
| 144 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.58664889 |
| 145 | biotin metabolic process (GO:0006768) | 2.58593619 |
| 146 | cellular response to interferon-beta (GO:0035458) | 2.58350099 |
| 147 | neutral lipid catabolic process (GO:0046461) | 2.57633574 |
| 148 | acylglycerol catabolic process (GO:0046464) | 2.57633574 |
| 149 | skeletal muscle adaptation (GO:0043501) | 2.57619776 |
| 150 | response to interferon-beta (GO:0035456) | 2.56257032 |
| 151 | cellular extravasation (GO:0045123) | 2.56130188 |
| 152 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.56098918 |
| 153 | protein retention in ER lumen (GO:0006621) | 2.55918103 |
| 154 | B cell receptor signaling pathway (GO:0050853) | 2.55709652 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.54702071 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54701641 |
| 157 | response to host (GO:0075136) | 2.54701641 |
| 158 | response to host defenses (GO:0052200) | 2.54701641 |
| 159 | regulation of granulocyte differentiation (GO:0030852) | 2.54588679 |
| 160 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.52978473 |
| 161 | negative regulation of interleukin-6 production (GO:0032715) | 2.52559707 |
| 162 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52479169 |
| 163 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52421880 |
| 164 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.51798139 |
| 165 | ethanol metabolic process (GO:0006067) | 2.51395894 |
| 166 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50889693 |
| 167 | protein complex disassembly (GO:0043241) | 2.49766580 |
| 168 | gas transport (GO:0015669) | 2.48569875 |
| 169 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.48151499 |
| 170 | NIK/NF-kappaB signaling (GO:0038061) | 2.48078050 |
| 171 | homocysteine metabolic process (GO:0050667) | 2.46490086 |
| 172 | negative regulation of heart growth (GO:0061117) | 2.46145583 |
| 173 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.46145583 |
| 174 | regulation of triglyceride catabolic process (GO:0010896) | 2.45272472 |
| 175 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.45268846 |
| 176 | modulation by virus of host process (GO:0019054) | 2.44656056 |
| 177 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.43978138 |
| 178 | cellular response to exogenous dsRNA (GO:0071360) | 2.43537501 |
| 179 | leukocyte degranulation (GO:0043299) | 2.42673340 |
| 180 | cellular ketone body metabolic process (GO:0046950) | 2.42531915 |
| 181 | positive regulation of interferon-beta production (GO:0032728) | 2.42252686 |
| 182 | desmosome organization (GO:0002934) | 2.41944608 |
| 183 | modulation by symbiont of host cellular process (GO:0044068) | 2.41907548 |
| 184 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41048241 |
| 185 | response to muramyl dipeptide (GO:0032495) | 2.40285149 |
| 186 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.40091779 |
| 187 | detection of biotic stimulus (GO:0009595) | 2.39703296 |
| 188 | lipid particle organization (GO:0034389) | 2.39635028 |
| 189 | regulation of translational termination (GO:0006449) | 2.39530541 |
| 190 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.39488960 |
| 191 | positive regulation of type 2 immune response (GO:0002830) | 2.38298617 |
| 192 | T-helper 1 type immune response (GO:0042088) | 2.37702781 |
| 193 | negative regulation of necroptotic process (GO:0060546) | 2.37162145 |
| 194 | positive regulation of interleukin-10 production (GO:0032733) | 2.36897727 |
| 195 | striated muscle atrophy (GO:0014891) | 2.36872766 |
| 196 | negative regulation of type I interferon production (GO:0032480) | 2.35589906 |
| 197 | mature B cell differentiation involved in immune response (GO:0002313) | 2.35315496 |
| 198 | cellular response to interferon-gamma (GO:0071346) | 2.35261519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.60399378 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47985969 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.85845849 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.61354245 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90869348 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.86845857 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.85338826 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.72641447 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64749279 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59987222 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57686383 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48447340 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47958058 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39573054 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28483329 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23558348 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17220581 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10767104 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06480077 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06011185 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05761015 |
| 22 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04487715 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99533498 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95636495 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93327691 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.92920028 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90271471 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87345872 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87051529 |
| 30 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85248254 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.81385859 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79433135 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79238784 |
| 34 | ATF3_27146783_Chip-Seq_COLON_Human | 1.77492086 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.77327856 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.76600169 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.74908306 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74234618 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.71781103 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71735987 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68959448 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66756989 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65212248 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.63452143 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60179097 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59064140 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57655298 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57025365 |
| 49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55966322 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.55927727 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54189651 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52658476 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49621357 |
| 54 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49166894 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47804038 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46548955 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44711354 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43166408 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42218729 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41735247 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36965781 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34184361 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33193534 |
| 64 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31596837 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31391844 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30641963 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29296751 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28873736 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28825825 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28240547 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27705398 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27122823 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26367296 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26105168 |
| 75 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24269784 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23528717 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23348786 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23303811 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22429285 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22265312 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21581410 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21409190 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20456481 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20228310 |
| 85 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19928595 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19353280 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19219928 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19048685 |
| 89 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18836134 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18585134 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18338735 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18207528 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 1.18007157 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17564569 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17264488 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17113179 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16678469 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16401709 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16064803 |
| 100 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16033827 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.15040983 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14909516 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.14543265 |
| 104 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14177123 |
| 105 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13398935 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13096702 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 1.12875779 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12660772 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 1.12343109 |
| 110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11988967 |
| 111 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11298595 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11110242 |
| 113 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09718354 |
| 114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09713967 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09595371 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09252243 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08539266 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06483891 |
| 119 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05453255 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04377635 |
| 121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04252800 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04142611 |
| 123 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03975479 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03411120 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02663155 |
| 126 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02637328 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02624612 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02608178 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01492077 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01152689 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00838212 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00589064 |
| 133 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00204789 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99086491 |
| 135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99010637 |
| 136 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98879102 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98171083 |
| 138 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98006940 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95939186 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95674462 |
| 141 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95674462 |
| 142 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95284611 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.94248167 |
| 144 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92614849 |
| 145 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91388920 |
| 146 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.91153068 |
| 147 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91150935 |
| 148 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90549278 |
| 149 | MAF_26560356_Chip-Seq_TH2_Human | 0.90317713 |
| 150 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90284373 |
| 151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89760985 |
| 152 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89757593 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89245675 |
| 154 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88630301 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87402259 |
| 156 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87342878 |
| 157 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.87237656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.53967459 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.22292181 |
| 3 | MP0003724_increased_susceptibility_to | 3.11669542 |
| 4 | MP0005451_abnormal_body_composition | 3.04792661 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.92490769 |
| 6 | MP0005360_urolithiasis | 2.92195903 |
| 7 | MP0009785_altered_susceptibility_to | 2.52510521 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.48661755 |
| 9 | MP0005025_abnormal_response_to | 2.43172701 |
| 10 | MP0000685_abnormal_immune_system | 2.42960616 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.39754186 |
| 12 | MP0004130_abnormal_muscle_cell | 2.38583595 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.36775114 |
| 14 | MP0001800_abnormal_humoral_immune | 2.33117984 |
| 15 | MP0002419_abnormal_innate_immunity | 2.33021551 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.30993815 |
| 17 | MP0005666_abnormal_adipose_tissue | 2.28977036 |
| 18 | MP0005083_abnormal_biliary_tract | 2.26587691 |
| 19 | MP0005387_immune_system_phenotype | 2.25757297 |
| 20 | MP0001790_abnormal_immune_system | 2.25757297 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.21643935 |
| 22 | MP0005671_abnormal_response_to | 2.21361300 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.19564657 |
| 24 | MP0003646_muscle_fatigue | 2.16337492 |
| 25 | MP0005365_abnormal_bile_salt | 2.10794016 |
| 26 | MP0002723_abnormal_immune_serum | 2.09710211 |
| 27 | MP0009278_abnormal_bone_marrow | 2.08316884 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 2.03502659 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.99115037 |
| 30 | MP0006082_CNS_inflammation | 1.98509909 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.96603644 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.95334049 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.94939933 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.94775408 |
| 35 | MP0001819_abnormal_immune_cell | 1.94324420 |
| 36 | MP0008260_abnormal_autophagy | 1.86786682 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.86062971 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.77960080 |
| 39 | MP0000751_myopathy | 1.73046102 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.72486605 |
| 41 | MP0005670_abnormal_white_adipose | 1.69566674 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.68455755 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.64220718 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.61333678 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.61202777 |
| 46 | MP0002398_abnormal_bone_marrow | 1.61072815 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.60862512 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.60465146 |
| 49 | MP0004381_abnormal_hair_follicle | 1.60448817 |
| 50 | MP0005275_abnormal_skin_tensile | 1.58952057 |
| 51 | MP0002132_abnormal_respiratory_system | 1.58448533 |
| 52 | MP0003866_abnormal_defecation | 1.57147375 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.55989488 |
| 54 | MP0005330_cardiomyopathy | 1.55906567 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.54956911 |
| 56 | MP0002405_respiratory_system_inflammati | 1.54540336 |
| 57 | MP0009764_decreased_sensitivity_to | 1.53224647 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.52759597 |
| 59 | MP0000716_abnormal_immune_system | 1.51438677 |
| 60 | MP0003252_abnormal_bile_duct | 1.50927256 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.50156386 |
| 62 | MP0005332_abnormal_amino_acid | 1.50117969 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.48224005 |
| 64 | MP0005310_abnormal_salivary_gland | 1.46102938 |
| 65 | MP0002796_impaired_skin_barrier | 1.45951098 |
| 66 | MP0005375_adipose_tissue_phenotype | 1.44675587 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.42195016 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.41094210 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.40446597 |
| 70 | MP0008469_abnormal_protein_level | 1.40282421 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.40098742 |
| 72 | MP0009840_abnormal_foam_cell | 1.39371493 |
| 73 | MP0006054_spinal_hemorrhage | 1.37925861 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35845901 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.33986990 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.33249849 |
| 77 | MP0003283_abnormal_digestive_organ | 1.32909520 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.31720639 |
| 79 | MP0002429_abnormal_blood_cell | 1.31291510 |
| 80 | MP0000747_muscle_weakness | 1.30627764 |
| 81 | MP0002722_abnormal_immune_system | 1.29933715 |
| 82 | MP0002971_abnormal_brown_adipose | 1.29497686 |
| 83 | MP0000609_abnormal_liver_physiology | 1.25802235 |
| 84 | MP0002269_muscular_atrophy | 1.23294300 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.21552055 |
| 86 | MP0003186_abnormal_redox_activity | 1.19925042 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19725924 |
| 88 | MP0000537_abnormal_urethra_morphology | 1.19298301 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 1.17805695 |
| 90 | MP0000749_muscle_degeneration | 1.16861311 |
| 91 | MP0004147_increased_porphyrin_level | 1.15956342 |
| 92 | MP0001756_abnormal_urination | 1.15904968 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 1.15799237 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 1.14776440 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 1.12555006 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 1.11209747 |
| 97 | MP0003075_altered_response_to | 1.10864512 |
| 98 | MP0004215_abnormal_myocardial_fiber | 1.10410508 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 1.10156040 |
| 100 | MP0010630_abnormal_cardiac_muscle | 1.09700896 |
| 101 | MP0005076_abnormal_cell_differentiation | 1.09377950 |
| 102 | MP0005501_abnormal_skin_physiology | 1.09105741 |
| 103 | MP0008775_abnormal_heart_ventricle | 1.07606779 |
| 104 | MP0004036_abnormal_muscle_relaxation | 1.05076829 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 1.04690754 |
| 106 | MP0003303_peritoneal_inflammation | 1.04384546 |
| 107 | MP0005410_abnormal_fertilization | 1.02961948 |
| 108 | MP0001765_abnormal_ion_homeostasis | 1.02622518 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 1.02166381 |
| 110 | MP0000490_abnormal_crypts_of | 1.01620019 |
| 111 | MP0003693_abnormal_embryo_hatching | 1.01093219 |
| 112 | MP0002396_abnormal_hematopoietic_system | 1.00710525 |
| 113 | MP0008961_abnormal_basal_metabolism | 1.00604765 |
| 114 | MP0004043_abnormal_pH_regulation | 1.00527513 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.99210277 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.97618359 |
| 117 | MP0010307_abnormal_tumor_latency | 0.97281856 |
| 118 | MP0001853_heart_inflammation | 0.97121234 |
| 119 | MP0005166_decreased_susceptibility_to | 0.97070553 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.96491977 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.96491977 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.96273284 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94888674 |
| 124 | MP0003195_calcinosis | 0.93931213 |
| 125 | MP0002106_abnormal_muscle_physiology | 0.93186836 |
| 126 | MP0001958_emphysema | 0.92483020 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.92481071 |
| 128 | MP0005397_hematopoietic_system_phenotyp | 0.92481071 |
| 129 | MP0001663_abnormal_digestive_system | 0.90545207 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.89225788 |
| 131 | MP0005023_abnormal_wound_healing | 0.89170994 |
| 132 | MP0005266_abnormal_metabolism | 0.88588527 |
| 133 | MP0000343_altered_response_to | 0.88120595 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.87232867 |
| 135 | MP0002060_abnormal_skin_morphology | 0.86684868 |
| 136 | MP0004510_myositis | 0.86653814 |
| 137 | MP0000733_abnormal_muscle_development | 0.86179937 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.86062997 |
| 139 | MP0001873_stomach_inflammation | 0.85808976 |
| 140 | MP0000858_altered_metastatic_potential | 0.85152661 |
| 141 | MP0002970_abnormal_white_adipose | 0.84383643 |
| 142 | MP0001849_ear_inflammation | 0.84306396 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.83052157 |
| 144 | MP0003828_pulmonary_edema | 0.82727127 |
| 145 | MP0002009_preneoplasia | 0.82499649 |
| 146 | MP0004947_skin_inflammation | 0.81917911 |
| 147 | MP0003436_decreased_susceptibility_to | 0.81673804 |
| 148 | MP0000477_abnormal_intestine_morphology | 0.80882226 |
| 149 | MP0008874_decreased_physiological_sensi | 0.80837919 |
| 150 | MP0010155_abnormal_intestine_physiology | 0.79896100 |
| 151 | MP0004019_abnormal_vitamin_homeostasis | 0.79774661 |
| 152 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79633451 |
| 153 | * MP0000598_abnormal_liver_morphology | 0.79015828 |
| 154 | MP0002972_abnormal_cardiac_muscle | 0.78707613 |
| 155 | MP0004233_abnormal_muscle_weight | 0.76801453 |
| 156 | MP0005167_abnormal_blood-brain_barrier | 0.76499176 |
| 157 | MP0001730_embryonic_growth_arrest | 0.76132160 |
| 158 | MP0009763_increased_sensitivity_to | 0.74898460 |
| 159 | MP0005165_increased_susceptibility_to | 0.72395462 |
| 160 | MP0004484_altered_response_of | 0.69878677 |
| 161 | MP0006035_abnormal_mitochondrial_morpho | 0.68231913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.44251242 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.39547146 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.37102559 |
| 4 | Myositis (HP:0100614) | 4.10206809 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 4.08747940 |
| 6 | Myoglobinuria (HP:0002913) | 3.92128762 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85290098 |
| 8 | Orchitis (HP:0100796) | 3.80363223 |
| 9 | Stomatitis (HP:0010280) | 3.73223729 |
| 10 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.72176652 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.57551916 |
| 12 | Hypochromic anemia (HP:0001931) | 3.53087539 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.50201819 |
| 14 | Optic neuritis (HP:0100653) | 3.50201819 |
| 15 | Multiple enchondromatosis (HP:0005701) | 3.40974178 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.26895665 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.23465765 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 3.23082362 |
| 19 | Increased IgE level (HP:0003212) | 3.21052353 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18584192 |
| 21 | Gout (HP:0001997) | 3.12647828 |
| 22 | Obstructive lung disease (HP:0006536) | 3.10539738 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.10539738 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.08695758 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 3.07035702 |
| 26 | Hyperglycinuria (HP:0003108) | 3.05041824 |
| 27 | Urticaria (HP:0001025) | 2.99134423 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 2.97848380 |
| 29 | Increased connective tissue (HP:0009025) | 2.92915520 |
| 30 | Abnormal cartilage morphology (HP:0002763) | 2.89320677 |
| 31 | Conjunctival hamartoma (HP:0100780) | 2.89191971 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88386874 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88386874 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88386874 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.88311105 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86289046 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.85346339 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.85172761 |
| 39 | Microcytic anemia (HP:0001935) | 2.80098618 |
| 40 | Recurrent skin infections (HP:0001581) | 2.77355120 |
| 41 | Difficulty climbing stairs (HP:0003551) | 2.75451616 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.73137469 |
| 43 | Meningitis (HP:0001287) | 2.72934145 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72911802 |
| 45 | Hyperammonemia (HP:0001987) | 2.70878639 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.68981145 |
| 47 | Abnormality of iron homeostasis (HP:0011031) | 2.68079608 |
| 48 | Encephalitis (HP:0002383) | 2.67917080 |
| 49 | Type 1 muscle fiber predominance (HP:0003803) | 2.64959531 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63928361 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.63928361 |
| 52 | Ketosis (HP:0001946) | 2.63385198 |
| 53 | Ketoacidosis (HP:0001993) | 2.60606035 |
| 54 | Sudden death (HP:0001699) | 2.59423173 |
| 55 | Hyporeflexia of lower limbs (HP:0002600) | 2.58548285 |
| 56 | Ventricular tachycardia (HP:0004756) | 2.50810251 |
| 57 | Recurrent viral infections (HP:0004429) | 2.50665944 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.50461831 |
| 59 | Paralysis (HP:0003470) | 2.47855663 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.46943832 |
| 61 | Difficulty running (HP:0009046) | 2.46851134 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.45432514 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.45432514 |
| 64 | Gingivitis (HP:0000230) | 2.44553159 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.44139938 |
| 66 | Muscle fiber splitting (HP:0003555) | 2.41579063 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.41311301 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39236233 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.39198413 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.36222557 |
| 71 | Abnormal number of erythroid precursors (HP:0012131) | 2.35532638 |
| 72 | Ulnar deviation of the wrist (HP:0003049) | 2.35202020 |
| 73 | Vasculitis (HP:0002633) | 2.33243717 |
| 74 | Visual hallucinations (HP:0002367) | 2.32330649 |
| 75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.31700446 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31234956 |
| 77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31234956 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.31188255 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.29502206 |
| 80 | Chronic otitis media (HP:0000389) | 2.29067652 |
| 81 | Colitis (HP:0002583) | 2.27533941 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.27204129 |
| 83 | Chest pain (HP:0100749) | 2.27000434 |
| 84 | Increased purine levels (HP:0004368) | 2.26301609 |
| 85 | Hyperuricemia (HP:0002149) | 2.26301609 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.25476635 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.25476635 |
| 88 | Fatigue (HP:0012378) | 2.23915597 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.23831533 |
| 90 | Nausea (HP:0002018) | 2.22280656 |
| 91 | Bundle branch block (HP:0011710) | 2.20167476 |
| 92 | Muscle stiffness (HP:0003552) | 2.19946531 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19943209 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.19412642 |
| 95 | Polycythemia (HP:0001901) | 2.18935340 |
| 96 | Petechiae (HP:0000967) | 2.18695683 |
| 97 | Abnormality of the nasal mucosa (HP:0000433) | 2.17055874 |
| 98 | Distal arthrogryposis (HP:0005684) | 2.16558695 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.15855956 |
| 100 | Muscle fiber inclusion bodies (HP:0100299) | 2.15471350 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13363670 |
| 102 | Hyperglycinemia (HP:0002154) | 2.13205657 |
| 103 | Progressive muscle weakness (HP:0003323) | 2.13176795 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.12379321 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.10617872 |
| 106 | Cellulitis (HP:0100658) | 2.10338555 |
| 107 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.09843323 |
| 108 | Rectal prolapse (HP:0002035) | 2.09711321 |
| 109 | Xanthomatosis (HP:0000991) | 2.08797783 |
| 110 | Ileus (HP:0002595) | 2.08795383 |
| 111 | Palpitations (HP:0001962) | 2.08727960 |
| 112 | Angiofibromas (HP:0010615) | 2.06945390 |
| 113 | Adenoma sebaceum (HP:0009720) | 2.06945390 |
| 114 | Arterial thrombosis (HP:0004420) | 2.05120775 |
| 115 | Protrusio acetabuli (HP:0003179) | 2.04712210 |
| 116 | Hemoptysis (HP:0002105) | 2.04016996 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.03642888 |
| 118 | Malnutrition (HP:0004395) | 2.03474504 |
| 119 | Granulocytopenia (HP:0001913) | 2.03035808 |
| 120 | Distal lower limb muscle weakness (HP:0009053) | 2.02940899 |
| 121 | Anorexia (HP:0002039) | 2.01496646 |
| 122 | Lymphangioma (HP:0100764) | 2.00924458 |
| 123 | Trismus (HP:0000211) | 1.99695143 |
| 124 | Nasal polyposis (HP:0100582) | 1.98937514 |
| 125 | Alkalosis (HP:0001948) | 1.97918010 |
| 126 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97594649 |
| 127 | Spastic diplegia (HP:0001264) | 1.96851763 |
| 128 | Acute hepatic failure (HP:0006554) | 1.93366051 |
| 129 | Ankle contracture (HP:0006466) | 1.93121195 |
| 130 | Abnormality of T cells (HP:0002843) | 1.92324675 |
| 131 | Hepatic necrosis (HP:0002605) | 1.91929535 |
| 132 | Amyloidosis (HP:0011034) | 1.91648898 |
| 133 | Deep venous thrombosis (HP:0002625) | 1.91353817 |
| 134 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.89764136 |
| 135 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.89764136 |
| 136 | Reticulocytosis (HP:0001923) | 1.89619432 |
| 137 | Myopathic facies (HP:0002058) | 1.89591275 |
| 138 | Recurrent bronchitis (HP:0002837) | 1.88884040 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.87335060 |
| 140 | Lipoatrophy (HP:0100578) | 1.86975095 |
| 141 | Flat acetabular roof (HP:0003180) | 1.86499197 |
| 142 | Abnormality of chloride homeostasis (HP:0011422) | 1.85886843 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83963746 |
| 144 | Episodic fever (HP:0001954) | 1.83563940 |
| 145 | Hamartoma of the eye (HP:0010568) | 1.83503012 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.83477699 |
| 147 | Global brain atrophy (HP:0002283) | 1.83400595 |
| 148 | Abnormality of T cell physiology (HP:0011840) | 1.81831431 |
| 149 | Increased serum ferritin (HP:0003281) | 1.81583159 |
| 150 | Frequent falls (HP:0002359) | 1.81403609 |
| 151 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.81239613 |
| 152 | Autoimmune hemolytic anemia (HP:0001890) | 1.81086722 |
| 153 | Fragile skin (HP:0001030) | 1.80676426 |
| 154 | Limb-girdle muscle atrophy (HP:0003797) | 1.80309996 |
| 155 | Hyperkalemia (HP:0002153) | 1.80305302 |
| 156 | Abnormality of the endocardium (HP:0004306) | 1.80193154 |
| 157 | Generalized aminoaciduria (HP:0002909) | 1.80159970 |
| 158 | Pulmonary infiltrates (HP:0002113) | 1.79982959 |
| 159 | Spontaneous hematomas (HP:0007420) | 1.79211115 |
| 160 | Absent phalangeal crease (HP:0006109) | 1.79041081 |
| 161 | Cerebral aneurysm (HP:0004944) | 1.78952483 |
| 162 | Alveolar cell carcinoma (HP:0006519) | 1.78797042 |
| 163 | Leukocytosis (HP:0001974) | 1.78759185 |
| 164 | Metabolic acidosis (HP:0001942) | 1.78727059 |
| 165 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.78589273 |
| 166 | Chronic sinusitis (HP:0011109) | 1.78518501 |
| 167 | Loss of speech (HP:0002371) | 1.77062673 |
| 168 | Pustule (HP:0200039) | 1.75527024 |
| 169 | Hydroxyprolinuria (HP:0003080) | 1.74984837 |
| 170 | Abnormality of proline metabolism (HP:0010907) | 1.74984837 |
| 171 | Hypoalphalipoproteinemia (HP:0003233) | 1.72960943 |
| 172 | Nemaline bodies (HP:0003798) | 1.72258301 |
| 173 | Late onset (HP:0003584) | 1.71613322 |
| 174 | Abnormality of the 1st metacarpal (HP:0010009) | 1.70816823 |
| 175 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70512582 |
| 176 | Ventricular fibrillation (HP:0001663) | 1.69920876 |
| 177 | Abnormal hemoglobin (HP:0011902) | 1.69895940 |
| 178 | Acanthosis nigricans (HP:0000956) | 1.69609600 |
| 179 | Abnormality of reticulocytes (HP:0004312) | 1.69496583 |
| 180 | Cupped ribs (HP:0000887) | 1.69429540 |
| 181 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69152528 |
| 182 | Cerebral edema (HP:0002181) | 1.69014898 |
| 183 | Poikilocytosis (HP:0004447) | 1.67623100 |
| 184 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67177932 |
| 185 | Ragged-red muscle fibers (HP:0003200) | 1.66900718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.46633760 |
| 2 | PKN2 | 4.12759967 |
| 3 | PDK3 | 2.95716577 |
| 4 | PDK4 | 2.95716577 |
| 5 | RIPK4 | 2.94915373 |
| 6 | BCKDK | 2.90205108 |
| 7 | TTN | 2.78446290 |
| 8 | ERN1 | 2.58642579 |
| 9 | TAOK2 | 2.52537494 |
| 10 | NME2 | 2.41085942 |
| 11 | EEF2K | 2.32745627 |
| 12 | IRAK4 | 2.30234566 |
| 13 | NEK1 | 2.26923962 |
| 14 | RIPK1 | 2.18847085 |
| 15 | LRRK2 | 2.11539155 |
| 16 | TESK1 | 2.10653246 |
| 17 | SCYL2 | 1.97363863 |
| 18 | PRPF4B | 1.92281499 |
| 19 | BLK | 1.83464705 |
| 20 | MAP3K14 | 1.79630356 |
| 21 | TNK2 | 1.77968757 |
| 22 | MAP3K10 | 1.77939318 |
| 23 | IKBKB | 1.73792252 |
| 24 | LMTK2 | 1.67510014 |
| 25 | PDK2 | 1.64799065 |
| 26 | IKBKE | 1.62700509 |
| 27 | MAPKAPK3 | 1.54174548 |
| 28 | MST1R | 1.51597872 |
| 29 | CSK | 1.50769610 |
| 30 | IRAK3 | 1.48170578 |
| 31 | ILK | 1.43415489 |
| 32 | PTK6 | 1.42685921 |
| 33 | MAP2K3 | 1.38903358 |
| 34 | MAP3K11 | 1.38383389 |
| 35 | FES | 1.37240952 |
| 36 | TLK1 | 1.35771175 |
| 37 | JAK3 | 1.30930128 |
| 38 | SIK1 | 1.28999248 |
| 39 | BTK | 1.28546292 |
| 40 | BMPR2 | 1.27999399 |
| 41 | NEK2 | 1.27410844 |
| 42 | SYK | 1.26303910 |
| 43 | PAK4 | 1.24777742 |
| 44 | MAPK12 | 1.23559221 |
| 45 | DMPK | 1.22418559 |
| 46 | SMG1 | 1.19596213 |
| 47 | TXK | 1.13972124 |
| 48 | FLT3 | 1.05768461 |
| 49 | EIF2AK1 | 1.01922815 |
| 50 | TAOK1 | 0.98131110 |
| 51 | RPS6KA4 | 0.96823632 |
| 52 | MAP3K13 | 0.96252249 |
| 53 | MAP3K3 | 0.95228532 |
| 54 | KSR2 | 0.94543159 |
| 55 | HCK | 0.94329422 |
| 56 | TBK1 | 0.92762402 |
| 57 | PIM1 | 0.92712124 |
| 58 | PIM2 | 0.92658011 |
| 59 | IRAK2 | 0.92631555 |
| 60 | WNK4 | 0.91510821 |
| 61 | PDGFRA | 0.91385609 |
| 62 | TESK2 | 0.91050628 |
| 63 | ZAP70 | 0.89766007 |
| 64 | KDR | 0.88596591 |
| 65 | BMX | 0.88503376 |
| 66 | MAP3K8 | 0.88438728 |
| 67 | CDK6 | 0.88164879 |
| 68 | LYN | 0.87834031 |
| 69 | CAMK1D | 0.86044711 |
| 70 | RPS6KB2 | 0.84654615 |
| 71 | TRPM7 | 0.83648261 |
| 72 | MAP2K2 | 0.83523640 |
| 73 | TGFBR2 | 0.82338087 |
| 74 | KIT | 0.80177045 |
| 75 | DAPK3 | 0.78978741 |
| 76 | FGFR4 | 0.78707024 |
| 77 | IRAK1 | 0.77262442 |
| 78 | NEK9 | 0.76589398 |
| 79 | STK10 | 0.76567477 |
| 80 | MATK | 0.73338597 |
| 81 | CDK4 | 0.72609043 |
| 82 | CSF1R | 0.71604122 |
| 83 | NME1 | 0.71387917 |
| 84 | MARK3 | 0.70071869 |
| 85 | MYLK | 0.70069348 |
| 86 | OBSCN | 0.69545943 |
| 87 | TAOK3 | 0.68919186 |
| 88 | PDPK1 | 0.68812892 |
| 89 | CAMKK1 | 0.68718240 |
| 90 | LCK | 0.66656200 |
| 91 | DYRK1B | 0.66434056 |
| 92 | MAPK11 | 0.66199315 |
| 93 | NEK6 | 0.65191663 |
| 94 | PAK2 | 0.63663877 |
| 95 | MAP2K1 | 0.63596137 |
| 96 | STK11 | 0.63310193 |
| 97 | MUSK | 0.63158710 |
| 98 | ABL2 | 0.63105068 |
| 99 | MAP4K1 | 0.62694523 |
| 100 | PHKG1 | 0.62658680 |
| 101 | PHKG2 | 0.62658680 |
| 102 | MAP3K5 | 0.62401939 |
| 103 | PIK3CG | 0.62317422 |
| 104 | PRKD3 | 0.62185976 |
| 105 | MAP3K7 | 0.61382961 |
| 106 | PDK1 | 0.61355536 |
| 107 | FGR | 0.60890341 |
| 108 | CHUK | 0.60814268 |
| 109 | OXSR1 | 0.60537462 |
| 110 | EPHB2 | 0.60313932 |
| 111 | TYK2 | 0.58641257 |
| 112 | EPHB1 | 0.58591396 |
| 113 | RET | 0.58340619 |
| 114 | SIK2 | 0.57454916 |
| 115 | MAPK15 | 0.54867536 |
| 116 | MAP3K1 | 0.54777660 |
| 117 | PIK3CA | 0.53500625 |
| 118 | ICK | 0.53490536 |
| 119 | HIPK2 | 0.53301914 |
| 120 | RPS6KC1 | 0.53172975 |
| 121 | RPS6KL1 | 0.53172975 |
| 122 | JAK2 | 0.53151215 |
| 123 | GRK5 | 0.52785876 |
| 124 | RPS6KA6 | 0.52654533 |
| 125 | MAP3K2 | 0.52529449 |
| 126 | MAP2K6 | 0.51161443 |
| 127 | MAP2K4 | 0.50551867 |
| 128 | LATS2 | 0.50403300 |
| 129 | GRK6 | 0.49981964 |
| 130 | GRK7 | 0.49328261 |
| 131 | CAMKK2 | 0.48871489 |
| 132 | LATS1 | 0.48123968 |
| 133 | PRKG2 | 0.47924243 |
| 134 | RPS6KA5 | 0.47916942 |
| 135 | WEE1 | 0.46966640 |
| 136 | ITK | 0.46935876 |
| 137 | MTOR | 0.46787632 |
| 138 | PRKAA2 | 0.45605244 |
| 139 | MARK2 | 0.45378989 |
| 140 | AURKB | 0.43043374 |
| 141 | MAPK4 | 0.42712667 |
| 142 | JAK1 | 0.42419390 |
| 143 | PTK2 | 0.42343222 |
| 144 | TEC | 0.41613510 |
| 145 | TTK | 0.41581551 |
| 146 | ACVR1B | 0.41502048 |
| 147 | STK3 | 0.41410462 |
| 148 | FER | 0.40602789 |
| 149 | PRKD2 | 0.40277046 |
| 150 | WNK3 | 0.39112600 |
| 151 | LIMK1 | 0.39066335 |
| 152 | AKT2 | 0.38989083 |
| 153 | TGFBR1 | 0.38412504 |
| 154 | DDR2 | 0.37486907 |
| 155 | DYRK3 | 0.36478882 |
| 156 | ALK | 0.34735423 |
| 157 | STK24 | 0.34424221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.09171717 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.34560617 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.01978635 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.97435911 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.84697873 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.71111169 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70283742 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70121661 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69984054 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68734339 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.62675845 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51711391 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.36244888 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.35583480 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30029363 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.15046254 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.11435587 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07121125 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06619136 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05912335 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04604754 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03278519 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99616960 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.98854925 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97980437 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96013609 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.95512211 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.93438764 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85450396 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79926687 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.79217641 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.76460550 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76215437 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.74883068 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74608169 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74113304 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69748495 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.68457194 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.68101478 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67518714 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.65807646 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.64963990 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64316219 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59115957 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.58979414 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56051789 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53473124 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49477677 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.46353676 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45839108 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41676007 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40807236 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40574770 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38087631 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35230485 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 1.33394357 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32995419 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30372689 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28523536 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28106315 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.26268703 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25093688 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23422659 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20597785 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19959646 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18604526 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14351621 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11947396 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08906502 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08603006 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08396004 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07028756 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06785322 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 1.02576943 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00568035 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.98968012 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97582530 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96844145 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95736541 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95675702 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.94704478 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93822979 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.93682873 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.92618949 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92383946 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90653036 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89367617 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88345040 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87933802 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86442781 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86042847 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.85224588 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83913601 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82491295 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80758804 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78429223 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77620830 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77508888 |
| 99 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76139481 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75532760 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71462378 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.71369893 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70789463 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68735683 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.68299459 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67951385 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67253491 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67235210 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66095761 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63991526 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60240188 |
| 112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60235431 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.59044013 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58786134 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56527954 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56230691 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55065371 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54494846 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53887739 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.53084287 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52881281 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52404895 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49218195 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48865649 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48755868 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47070871 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46860064 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46564943 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46433342 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46360655 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46116985 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45673870 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45194610 |
| 134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44938596 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44917867 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44817286 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44622767 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.44486044 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44442635 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.43864528 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43862576 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42994713 |
| 143 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41240654 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41015319 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38483174 |
| 146 | DNA replication_Homo sapiens_hsa03030 | 0.38464204 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38458409 |
| 148 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37785407 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37639679 |
| 150 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37257924 |
| 151 | Focal adhesion_Homo sapiens_hsa04510 | 0.36573070 |
| 152 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36488740 |
| 153 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35432760 |
| 154 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34626266 |
| 155 | Amoebiasis_Homo sapiens_hsa05146 | 0.33860120 |
| 156 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33534060 |
| 157 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33166015 |
| 158 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33085257 |
| 159 | Lysine degradation_Homo sapiens_hsa00310 | 0.33064998 |
| 160 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32556134 |
| 161 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31876235 |
| 162 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30892501 |
| 163 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30517098 |
| 164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30486853 |
| 165 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30359648 |
| 166 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29416755 |
| 167 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28671386 |
| 168 | Apoptosis_Homo sapiens_hsa04210 | 0.27050606 |
| 169 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26888450 |

